LM, C., JS, F., N, N., JJ, M., PA, S., KL, B., . . . CC, L. (2019). Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis. Oncogene, 38(44), 6959. https://doi.org/10.1038/s41388-019-0913-4
Chicago Style (17th ed.) CitationLM, Cook, Frieling JS, Nerlakanti N, McGuire JJ, Stewart PA, Burger KL, Cleveland JL, and Lynch CC. "Betaglycan Drives the Mesenchymal Stromal Cell Osteogenic Program and Prostate Cancer-induced Osteogenesis." Oncogene 38, no. 44 (2019): 6959. https://doi.org/10.1038/s41388-019-0913-4.
MLA (9th ed.) CitationLM, Cook, et al. "Betaglycan Drives the Mesenchymal Stromal Cell Osteogenic Program and Prostate Cancer-induced Osteogenesis." Oncogene, vol. 38, no. 44, 2019, p. 6959, https://doi.org/10.1038/s41388-019-0913-4.